Company news: LGP; Cann Global; Medcan; Incannex; Medlab; Emyria; RestoreMe; Releaf Group; Levin Health by Martin Lane and Steve Jones November 30, 2022April 29, 2024 Little Green Pharma (LGP) has received ethics approval to proceed with a phase III clinical trial […]
Two-year study of 4,000 patients reveals cannabis is ‘safe and efficacious’ by Steve Jones November 23, 2022April 29, 2024
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022April 29, 2024
Company news: Emyria; Ananda Wellness; InhaleRx; Cann Global; HFA by Steve Jones September 28, 2022April 29, 2024
We need to talk about flower – the vexing challenge of dried cannabis by Steve Jones September 21, 2022April 29, 2024
Emyria posts A$7m loss but insists 2023 will be ‘momentous’ by Steve Jones August 30, 2022April 29, 2024
Andrew Forrest targets health-tech startups with $A250m fund by Martin Lane August 23, 2022April 29, 2024
Company news: Bod; Neurotech International; Emyria; Creso Pharma by Martin Lane August 23, 2022April 29, 2024
Cannabis risks becoming a ‘borderline supplement’ unless it evolves, warns Emyria chief by Steve Jones August 18, 2022April 29, 2024
Company news: MGC Pharma; Emyria; Incannex, IvyMed Clinic by Steve Jones August 17, 2022April 29, 2024